Jk. Miyashiro et Eo. Feigl, FEEDFORWARD CONTROL OF CORONARY BLOOD-FLOW VIA CORONARY BETA-RECEPTORSTIMULATION, Circulation research, 73(2), 1993, pp. 252-263
It is usually assumed that the increase in coronary blood flow observe
d with norepinephrine occurs through local metabolic vasodilation seco
ndary to cardiac beta-receptor activation. However, direct feedforward
beta-receptor-mediated coronary vasodilation is also a possibility. I
n dogs with alpha-receptor blockade, the left circumflex artery was pe
rfused at constant pressure. The vasodilator effect of intracoronary n
orepinephrine injections was determined during prolonged diastoles to
avoid the chronotropic and inotropic effects of norepinephrine. Norepi
nephrine caused a dose-dependent increase in coronary blood flow that
was attenuated by both the selective beta1-antagonist practolol and th
e selective beta2-antagonist ICI 118 551. These data indicate that nor
epinephrine activates beta1- and beta2-receptors in coronary resistanc
e vessels to cause vasodilation independent of inotropic and chronotro
pic effects. The physiological significance of coronary beta-receptor-
mediated vasodilation was investigated in the beating heart. The coron
ary blood flow response and coronary venous oxygen tension response we
re compared when myocardial oxygen consumption was increased over the
same range by one of three positive inotropic interventions: (1) norep
inephrine, (2) paired-pulse stimulation, or (3) norepinephrine after a
lpha-blockade. During norepinephrine infusion (intervention 1), corona
ry venous oxygen tension decreased, indicating that the match between
myocardial oxygen consumption and oxygen delivery is not maintained wh
en coronary blood flow is controlled by alpha- and beta-receptors in a
ddition to local metabolic factors. Paired-pulse stimulation (interven
tion 2) also resulted in a decrease in coronary venous oxygen tension,
demonstrating that the balance between oxygen consumption and deliver
y is not maintained when blood flow is controlled by local metabolic f
actors alone. However, when coronary beta-receptor-mediated vasodilati
on was unmasked by alpha-blockade, norepinephrine infusion (interventi
on 3) produced no change in coronary venous oxygen tension. Therefore,
coronary beta-receptor vasodilation helps maintain the balance betwee
n flow and metabolism in a feedforward manner in the beating heart.